SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001308179-22-000120
Filing Date
2022-03-25
Accepted
2022-03-25 08:01:18
Documents
6

Document Format Files

Seq Description Document Type Size
1 AMNEAL PHARMACEUTICALS, INC. - DEF 14A larmx2022_defa14a.htm DEFA14A 9379
2 GRAPHIC check01.jpg GRAPHIC 1441
3 GRAPHIC larmx2022_notice1.jpg GRAPHIC 315393
4 GRAPHIC larmx2022_notice2.jpg GRAPHIC 231677
5 GRAPHIC logo.jpg GRAPHIC 18550
6 GRAPHIC uncheck.jpg GRAPHIC 1060
  Complete submission text file 0001308179-22-000120.txt   793455
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38485 | Film No.: 22768278
SIC: 2834 Pharmaceutical Preparations